Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-12-03T19:24:05.968Z Has data issue: false hasContentIssue false
  • English
  • Français

Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries – CORRIGENDUM

Published online by Cambridge University Press:  17 October 2023

David Watkins ,
Sali Ahmed  and
Sarah Pickersgill
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Corrigendum
Information
Journal of Benefit-Cost Analysis , Volume 14 , Issue S1 , Spring 2023 , pp. 356
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the Society for Benefit-Cost Analysis

Saleema Razvi was incorrectly listed as an author on this paper. The article has been updated to reflect this.

References

Watkins, D., Ahmed, S., Pickersgill, S.. 2023. “Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries.” Journal of Benefit-Cost Analysis, 1–17. doi:10.1017/bca.2023.25CrossRefGoogle Scholar